Neuroscience & Mental Health
Huntington’s Disease Effectively Treated for the First Time: UK Gene Therapy Trial Achieves ~75% Slower Progression
2025-09-25
Fighting Alzheimer’s Disease with a ‘Younger’ Brain? The Science of Brain Age and Resilience
2025-09-21
$58B Weight Loss Drug Market Diversifies: A Look at the Therapeutics of Cardiovascular, Alzheimer’s, Parkinson’s, and Neurodegenerative Diseases
2025-09-09
What Can the Cowboys vs Eagles Game, Jalen Carter, and Amari Cooper Tell Us About NFL Injuries and Sports Medicine?
2025-09-05
Protein Clues to Bipolar Disorder: Japanese Study Uncovers Degeneration in Paraventricular Thalamus
2025-09-04
At-Home Alzheimer’s Therapy: FDA Clears Leqembi IQLIK Autoinjector for Maintenance Dosing
2025-09-03
From Nose to Nerves: World-First Clinical Trial Puts Stem Cells in the Spotlight for Spinal Cord Injury
2025-08-28
AbbVie Buys Bretisilocin from Gilgamesh in $1.2B Deal to Expand Depression Drug Pipeline–Another Win in the Psychedelic Space?
2025-08-27
FDA Approval of KETARx Unlocks New Era of Ketamine Treatments for Pain Mental Health and Neurological Disorders
2025-08-12
The iPSC & Small Molecule Convergence: Redefining What’s Possible in CNS Drug Development
2025-08-07
LATEST
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California





